The Geller-Seifter conflict paradigm with incremental shock
- PMID: 37541
- DOI: 10.1007/BF00427123
The Geller-Seifter conflict paradigm with incremental shock
Abstract
The typical Geller-Seifter conflict paradigm for predicting clinical efficacy of anxiolytics is a mult VI/CRF schedule in which response rates in the CRF (conflict) portion are depressed by response-contingent electric shock. In 1-h sessions, anxiolytics raise the depressed conflict rates. Recently it was shown that replacing the single shock level with an arrangement whereby shock begins at zero and is increased with each response in the conflict portion produced more orderly data and facilitated training and maintenance of experimental subjects; chlordiazepoxide was the test drug. In the present study, those results are replicated in 30-min sessions, and the incremental paradigm is demonstrated to be as specific for anxiolytics as the standard Geller-Seifter paradigm. The possibility of very short sessions is suggested.
Similar articles
-
Cumulative dose-effect curves in a conflict test with incremental shock.Psychopharmacology (Berl). 1982;78(2):195-6. doi: 10.1007/BF00432263. Psychopharmacology (Berl). 1982. PMID: 6817378
-
Benzodiazepine effects upon Geller-Seifter conflict test in rats: analysis of individual variability.Pharmacol Biochem Behav. 1982 Jul;17(1):43-8. doi: 10.1016/0091-3057(82)90260-x. Pharmacol Biochem Behav. 1982. PMID: 6126890
-
Comparison of anti-conflict drug effects in three experimental animal models of anxiety.Psychopharmacology (Berl). 1981;74(3):290-6. doi: 10.1007/BF00427112. Psychopharmacology (Berl). 1981. PMID: 6115450
-
[Assessment of anxiolytics (1)--Geller-type conflict tests].Nihon Shinkei Seishin Yakurigaku Zasshi. 1995 Apr;15(2):115-23. Nihon Shinkei Seishin Yakurigaku Zasshi. 1995. PMID: 7796316 Review. Japanese.
-
Pharmacological studies of sleep and dreaming: chemical and clinical relationships.Biol Psychiatry. 1969 Jul;1(3):243-58. Biol Psychiatry. 1969. PMID: 4311771 Review. No abstract available.
Cited by
-
Cumulative dose-effect curves in a conflict test with incremental shock.Psychopharmacology (Berl). 1982;78(2):195-6. doi: 10.1007/BF00432263. Psychopharmacology (Berl). 1982. PMID: 6817378
-
AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.J Alzheimers Dis. 2016 May 25;53(2):583-620. doi: 10.3233/JAD-151146. J Alzheimers Dis. 2016. PMID: 27232215 Free PMC article. Review.
-
The staircase test: some evidence of nonspecificity for anxiolytics.Psychopharmacology (Berl). 1986;89(1):14-9. doi: 10.1007/BF00175182. Psychopharmacology (Berl). 1986. PMID: 2874582
-
Measuring Behavior in the Home Cage: Study Design, Applications, Challenges, and Perspectives.Front Behav Neurosci. 2021 Sep 24;15:735387. doi: 10.3389/fnbeh.2021.735387. eCollection 2021. Front Behav Neurosci. 2021. PMID: 34630052 Free PMC article.
-
Touchscreen-based assessment of risky-choice in mice.Behav Brain Res. 2020 Sep 1;393:112748. doi: 10.1016/j.bbr.2020.112748. Epub 2020 Jun 10. Behav Brain Res. 2020. PMID: 32531231 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources